Tertiary patenting on drug – device combination products in the United States
Nature Biotechnology 36, 142 (2018).
doi:10.1038/nbt.4078
Authors: Reed F Beall & Aaron S Kesselheim
Drug–device combination products are becoming increasingly prevalent, with many lasting years beyond the expiration date of primary and secondary patents on the drug itself.
Source: Nature Biotechnology - Category: Biotechnology Authors: Reed F Beall Aaron S Kesselheim Tags: Feature Source Type: research
More News: Biotechnology | USA Health